TARGT IndiegeneTM
Promise of Precision
TARGT Indiegene is one of the largest cancer gene panels in the world developed by comprehensively profiling the whole-exome and transcriptome of 1500+ tumor samples across 28 cancer types covering well-known oncogenic driver mutations and other oncogenic variations having clinical and research value.
TARGT Indiegene is the only pan solid cancer panel constituting unique 1212 genes. The scope of the testing includes 1064 genes for SNVs/Indels, 570 genes for Copy Number Alterations, 299 genes associated with Gene-Fusions, which includes common, rare fusions as well as novel fusion partners along with Immunotherapy Biomarkers (TMB, MSI by NGS, and PD-L1 by IHC). 
Provides the oncologist(s) with clinically actionable insights from individual patients’ tumor tissue to make informed treatment decisions.
Consult our Genetic Counselor to find the right test for you.
Kindly fill the form below to download our